Real-Life Evidence on Stroke Prevention in SPAF
NCT02485873
·
clinicaltrials.gov ↗
COMPLETED
Status
8607
Enrollment
INDUSTRY
Sponsor class
Conditions
Atrial Fibrillation (Prevention of Stroke)
Interventions
DRUG:
Rivaroxaban (Xarelto, BAY59-7939)
DRUG:
Vitamin K antagonists
Sponsor
Bayer
Collaborators
[object Object]